Related Experiment Videos
Inducible nitric oxide synthase--time for reappraisal
Philipp Lirk1, Georg Hoffmann, Josef Rieder
1Dept. of Anesthesiology and Critical Care Medicine, Anichstr. 35, 6020 Innsbruck, Austria.
Current Drug Targets. Inflammation and Allergy
|October 17, 2003
Summary
Inducible nitric oxide synthase (iNOS) generates nitric oxide (NO), impacting inflammation, infection, and cancer. Careful iNOS inhibition is crucial, balancing therapeutic potential against essential physiological roles.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathophysiology
Background:
- Inducible nitric oxide synthase (iNOS) produces nitric oxide (NO) from L-arginine.
- iNOS-derived NO is vital in physiological processes and diseases like inflammation, infection, and cancer.
- iNOS is recognized as a potential disease marker and therapeutic target.
Purpose of the Study:
- To review the NOS enzyme family, their regulation, and roles.
- To explore iNOS's involvement in inflammation and neoplastic diseases.
- To discuss therapeutic implications of targeting iNOS.
Main Methods:
- Literature review of iNOS function and regulation.
- Analysis of iNOS's role in host defense and infection clearance.
- Examination of iNOS's contribution to tumorigenesis and cancer progression.
Main Results:
- iNOS mediates host defense but excess NO can cause tissue damage (e.g., septic shock).
- iNOS activity is linked to tumor progression, metastasis, and differentiation.
- Careful consideration of NO's essential functions is needed when using iNOS inhibitors.
Conclusions:
- iNOS is a critical enzyme with dual roles in health and disease.
- Understanding iNOS regulation and function is key for therapeutic strategies in inflammation and cancer.
- Targeting iNOS offers potential but requires careful clinical application.